| 000 | 01085 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515161320.0 | ||
| 264 | 0 | _c20090429 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1573-675X | ||
| 024 | 7 |
_a10.1007/s10495-009-0326-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhivotovsky, Boris | |
| 245 | 0 | 0 |
_aClinical perspectives of cell death: where we are and where to go... _h[electronic resource] |
| 260 |
_bApoptosis : an international journal on programmed cell death _cApr 2009 |
||
| 300 |
_a333-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTerminology as Topic |
| 700 | 1 | _aOrrenius, Sten | |
| 773 | 0 |
_tApoptosis : an international journal on programmed cell death _gvol. 14 _gno. 4 _gp. 333-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10495-009-0326-x _zAvailable from publisher's website |
| 999 |
_c18680656 _d18680656 |
||